Fufangdanshen Tablets + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
49
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Vascular Dementia
Conditions
Vascular Dementia
Trial Timeline
Sep 1, 2012 → Dec 1, 2015
NCT ID
NCT01761227About Fufangdanshen Tablets + Placebo
Fufangdanshen Tablets + Placebo is a phase 2 stage product being developed by Guangzhou Baiyunshan Pharmaceutical Holdings for Vascular Dementia. The current trial status is completed. This product is registered under clinical trial identifier NCT01761227. Target conditions include Vascular Dementia.
Hype Score Breakdown
Clinical
17
Activity
12
Company
7
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01761227 | Phase 2 | Completed |
Competing Products
20 competing products in Vascular Dementia